Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment

Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment—Part 2

Published:2011-01 Issue:1 Volume:7 Page:110-123
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Evans Denis A.¹²,Grodstein Francine³⁴,Loewenstein David⁵⁶,Kaye Jeffrey⁷⁸⁹,Weintraub Sandra¹⁰¹¹

Affiliation:

1. Rush Institute on Healthy AgingRush University Medical CenterChicagoILUSA

2. Department of Internal MedicineRush University Medical CenterChicagoILUSA

3. Department of Epidemiology, School of Public HealthHarvard UniversityBostonMAUSA

4. Brigham and Women's HospitalBostonMAUSA

5. Department of Psychiatry and Behavioral Sciences, Miller School of MedicineUniversity of MiamiMiamiFLUSA

6. Wien Center for Alzheimer's Disease and Memory DisordersMount Sinai Medical CenterMiamiFLUSA

7. Oregon Center for Aging and TechnologyOregon Health and Science UniversityPortlandORUSA

8. Layton Aging and Alzheimer's Disease CenterOregon Health and Science UniversityPortlandORUSA

9. Portland Veterans Affairs Medical CenterPortlandORUSA

10. Department of Psychiatry and Behavioral Sciences, Feinberg School of MedicineNorthwestern UniversityChicagoILUSA

11. Cognitive Neurology and Alzheimer's Disease Center, Feinberg School of MedicineNorthwestern UniversityChicagoILUSA

Funder

Intel Corporation

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2010.11.008

Reference89 articles.

1. Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment—Part 1

2. Neuropathology of older persons without cognitive impairment from two community-based studies

3. Neuropathological and Neuropsychological Changes in “Normal” Aging

4. Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease

5. Alzheimer Neuropathologic Alterations in Aged Cognitively Normal Subjects

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marine n‐3 fatty acids and cognitive change among older adults in the VITAL randomized trial;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2022-01

2. Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial;Scientific Reports;2021-12

3. ARMADA: Assessing reliable measurement in Alzheimer’s disease and cognitive aging project methods;Alzheimer's & Dementia;2021-11-17

4. Comparison of the predictive accuracy of multiple definitions of cognitive impairment for incident dementia: a 20-year follow-up of the Whitehall II cohort study;The Lancet Healthy Longevity;2021-07

5. Learning From Clinical Consensus Diagnosis in India to Facilitate Automatic Classification of Dementia: Machine Learning Study;JMIR Mental Health;2021-05-10